Veeva Systems management check

VEEV · Health Care · Health Care Technology · CEO Mr. Gassner

Filings as of

63
Management score, ranked 280th of 487 · 31st of 60 in Health Care4 good · 1 to watch · 2 flaggedStrongest: CEO cost · Weakest: owner returns · Best and worst run in Health Care →

Closest peers in Health Care Technology

  1. 277PFEPfizer63
  2. 280VEEVVeeva Systems63
  3. 281WSTWest Pharmaceutical Services63
  4. 284RMDResMed63
  5. 286GEHCGE HealthCare62
  6. 324SOLVSolventum59

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$74Peers$125

    What $100 became since fiscal 2022

    016th
    Detail

    $100 invested at the start of fiscal 2022 grew to $74, against $125 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20222026

    Pay actually paid $100 value, each on its own scale

    7740th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.54 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.05% of net income

    $471k pay · $908.9m net income, FY2026

    0.1%1%3%10%
    100100th
    Detail

    $471k of reported pay in fiscal 2026, against $908.9m of net income.

  • Watch

    Do they own the stock?

    Insiders are selling

    6 mo: ▲ $0 bought · ▼ $16.2m sold

    ——
    Detail

    4 insiders sold $16.2m in the last six months and none bought. 9 of 12 sales ran on pre-arranged 10b5-1 plans.

  • Flag

    Are owners being diluted?

    Share count growing2021 · 162m2025 · 167m

    Diluted shares +1.1% a year; flagged above +2%

    0%10%20%

    Stock pay 14.8% of revenue

    2014th
    Detail

    Diluted shares changed +1.1% a year over the last three fiscal years. Stock-based pay was 14.8% of revenue in the latest year.

  • Good

    Is leadership stable?

    9 leadership filings in 3 years

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Mr. Gassner

    8056th
    Detail

    CEO in the pay table: Mr. Gassner. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed May 4, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
−$93.7m$95.2m$284.2m$10020222023202420252026$74$125

Pay tied most to not included

Other key measuresStock Price

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2026Mr. Gassner$471k−$88.1m$3.8m$74$125$908.9m
2025Mr. Gassner$172.4m$284.2m$2.7m$84$147$714.1m
2024Mr. Gassner$421k$31.8m$3.8m$75$136$525.7m
2023Mr. Gassner$392k−$93.7m$7.5m$62$90$487.7m
2022Mr. Gassner$350k−$57.9m$2.8m$86$111$427.4m

Insiders and the CEO's stakeSelling

4 insiders sold $16.2m in the last six months and none bought. 9 of 12 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldThomas D. SchwengerPres. & Chief Customer Officer · 10b5-1 plan$13.1mSep 14, 2026
  • SoldJonathan FaddisSVP, Gen. Counsel, Secretary · 10b5-1 plan$1.6mOct 14, 2026
  • SoldDaniel J RizzoEVP, Sales, Consulting, & Svcs$1.3mOct 2, 2026
  • SoldPriscilla HungDirector$196kSep 9, 2026

Leadership and governance on file

20222023202420252026Leadership 16Votes 5
All 16 filings

Latest shareholder vote results: Jun 18, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $169.9m returned to owners in buybacks and dividends, 6% of net income, and $1.9bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$454.5m$908.9m20212022202320242025Shares162m162m163m165m167m
Show the figures
Fiscal year20212022202320242025
Revenue$1.9bn$2.2bn$2.4bn$2.7bn$3.2bn
Net income$427.4m$487.7m$525.7m$714.1m$908.9m
Stock-based pay$234.6m$351.9m$393.7m$437.4m$472.7m
Buybacks——$0$0$169.9m
Dividends—————
Diluted shares162m162m163m165m167m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.